NMPA issued eleven Innovation Evaluation Reports to 2nd Quarter, 2021, guiding overseas and domestic manufacturers on how to go through the fast-track channel.
As NMPA standardizes and streamlines the review process for fast-track approvals, it is vital for manufacturers to comply with NMPA requirements if you have similar devices entering China market. The Evaluation Reports, ten-to-twenty-page long, describe the following aspects:
- Pre-clinical Trial
- product performance research
- BC (biocompatibility)
- sterilization
- product expiration date and packaging
- animal study
- … …
- Clinical Trial
- duration
- number of participants
- efficacy endpoints
- safety endpoints
- … …
- Risk-benefit Analysis
Complete List
For an English copy of following NMPA Innovation Review Report listed above, please email us at ChinaMedDevice.com. We charge nominal fees for the translation.
- Roche Diagnostics: Rabbit Anti-Human PD-L1/CD274 Monoclonal Antibody (Clone SP142)
- Sequent Medical: Aneurysm Embolization System
- Shenzhen Ruixin: Coronary CT blood flow reserve calculation software
- Xiamen Zhishan: Fully Automatic Medical PCR Analysis System
- Beijing Huifukang: peripheral nerve socket
- Zhejiang Batai: Paclitaxel-eluting PTCA balloon dilatation catheter
- Shenzhen xianjian: Temporary pacemaker
- Baikangxin: Respiratory Pathogenic Bacteria Nucleic Acid Detection Kit
- Tianjin Yingtai: Steep Pulse Therapy Apparatus
- Shanghai MicroPort: Three-dimensional electronic abdominal endoscopy
- Shanghai Xinchao Bio: Helicobacter pylori 23S rRNA gene mutation detection kit
How to Qualify the Innovation Pathway
The “Innovation Approval Procedure for Medical Devices” lists four criteria for domestic or imported Class II / Class III medical devices manufacturers to apply:
- Provide significant clinical application value,
- Own valid invention patent and have China Patent & Trade Office coverage,
- Complete the preliminary study on a prototype with traceable data, and
- Have an authorized in-country legal entity.
Click HERE to get an English copy of Innovation Device Approval Procedure, issued by NMPA in November 2018.